Twelve of the largest US health systems have joined Israeli clinical AI leader Aidoc to launch the Diagnostic AI Consortium, an ambitious cross-institution collaboration announced on 14 August 2026 to attack what its members call America's "diagnostic capacity crisis" with always-on artificial intelligence.
A 20-million-patient coalition
The founding members — Advocate Health, Cedars-Sinai Health System, Hartford Healthcare, Houston Methodist, Mercy, Mount Sinai Health System, Northwell Health, Northwestern Medicine, Sutter Health, University of Florida Health, University Hospitals of Cleveland and WellSpan Health — collectively care for nearly 20 million patients each year. That footprint gives the group the statistical power to test whether diagnostic AI can move the needle on missed findings, time-to-diagnosis and downstream care escalation.
The consortium will co-design future AI-enabled diagnostic workflows, measure their impact on safety, quality and speed across member sites, and translate what works into shared implementation and governance playbooks any health system can adopt.
Aidoc supplies the picks and shovels
Aidoc, founded in 2016 and already deployed in more than 1,600 hospitals, will provide the technical spine. The company's aiOS enterprise platform will integrate the participating hospitals' EHR, PACS, scheduling and reporting stacks, while its new Clinical AI Reasoning Engine, or CARE, will underpin cross-modality reasoning across radiology, cardiology and neurovascular workflows.
Timeline, evidence and industry stakes
Initial evidence from the consortium is expected in 2027. That deliverable will land in a market where AI diagnostics is already crossing the credibility threshold: Aidoc itself won an FDA Breakthrough Device tag for its First Read radiology reports in June and cleared a CT triage platform that flags 14 critical findings a few weeks earlier. The consortium formalises what informal customer councils have been doing for years — but backed by dedicated governance and prospective outcome measurement.
The move also lands as the EU AI Act begins active enforcement of transparency rules on medical AI, a shift now reshaping AI product design from Brussels to New York. By moving early on shared governance, Aidoc and its partners are trying to write the diagnostic-AI playbook before regulators or payers write it for them.
Reporting based on coverage from PRNewswire (via University Hospitals of Cleveland), Modern Healthcare, Becker's Hospital Review and Healthcare IT News.